WHO WE ARE
WHO WE ARE
Stegram Pharmaceuticals is a United Kingdom, USA and Canada Pharmaceutical Enterprise approved and FDA registered GMP contract provider of integrated chemistry, drug development and manufacturing services to the pharmaceutical and biotechnology industries. We bring 30 years of experience to our client’s projects and emphasize quality, speed and flexibility.
Our full range of services in-house (drug discovery, flow chemistry, formulation and process development, custom synthesis, cGMP sterile fill/finish, cGMP API manufacturing and/or dosage form manufacturing) all at one location enables us to be adaptable, flexible and cost-effective.
The integration of process development, API manufacturing and finished dose manufacturing at one location can accelerate drug discovery and development programs. Our range of contract development and manufacturing capabilities include aseptic liquid fill and difficult aseptic powder fills.
As a service to the R&D community, Stegram Pharmaceuticals has a Research Molecules catalogue of over 2000 fine chemicals, including labelled compounds, metabolites, impurities, and natural compounds.
“Our ongoing commitment to our clients, peers and the business community is reflected in our CMO 2020 and 2017 Leadership Awards from Life Science Leader in the categories of Quality, Reliability, Capabilities, Expertise, Compatibility and Development.
Sector: Pharmaceutical Dosage Form Manufacturing, Active Pharmaceutical Ingredient Manufacturing, Fine Chemical Manufacturing, Development Services, Research Services, and Biotechnology.
Mission: To benefit the world by being the ultimate drug development and manufacturing resource for our global customers.
Financing: Privately held and self-funded.
Management: Strong management team with diverse pharmaceutical, chemical and biotechnology backgrounds and customer service orientation. Extensive experience in managing complex and technically challenging projects. Stegram Pharmaceuticals Services offers a wide range of integrated scientific services including discovery, development and manufacturing:
Stegram Pharmaceuticals is a United Kingdom, USA and Canada Pharmaceutical Enterprise approved and FDA registered GMP contract provider of integrated chemistry, drug development and manufacturing services to the pharmaceutical and biotechnology industries. We bring 30 years of experience to our client’s projects and emphasize quality, speed and flexibility.
Our full range of services in-house (drug discovery, flow chemistry, formulation and process development, custom synthesis, cGMP sterile fill/finish, cGMP API manufacturing and/or dosage form manufacturing) all at one location enables us to be adaptable, flexible and cost-effective.
The integration of process development, API manufacturing and finished dose manufacturing at one location can accelerate drug discovery and development programs. Our range of contract development and manufacturing capabilities include aseptic liquid fill and difficult aseptic powder fills.
As a service to the R&D community, Stegram Pharmaceuticals has a Research Molecules catalogue of over 2000 fine chemicals, including labelled compounds, metabolites, impurities, and natural compounds.
“Our ongoing commitment to our clients, peers and the business community is reflected in our CMO 2020 and 2017 Leadership Awards from Life Science Leader in the categories of Quality, Reliability, Capabilities, Expertise, Compatibility and Development.
Sector: Pharmaceutical Dosage Form Manufacturing, Active Pharmaceutical Ingredient Manufacturing, Fine Chemical Manufacturing, Development Services, Research Services, and Biotechnology.
Mission: To benefit the world by being the ultimate drug development and manufacturing resource for our global customers.
Financing: Privately held and self-funded.
Management: Strong management team with diverse pharmaceutical, chemical and biotechnology backgrounds and customer service orientation. Extensive experience in managing complex and technically challenging projects. Stegram Pharmaceuticals Services offers a wide range of integrated scientific services including discovery, development and manufacturing:
DISCOVERY
- Medicinal Chemistry
- Contract Research
DEVELOPMENT
- Polymorphic Screening
- Synthetic Feasibility Analysis
- Synthetic Route Development
- Process Optimization
- Conjugation
- Scale Up of Difficult Chemistry
- Heterocyclic Chemistry
- Natural Compounds
- Inert Atmosphere Chemistry
- Analytical Development Services
- Analytical Reference Standards
- Accelerated Stability Testing
- Microbiology Services
- SEC-MALS
- Drug Analogue Developmen
MANUFACTURING
Dosage Forms
- cGMP Sterile Filling Services
- Aseptic Vial Filling
- Sterile Lyophilized Vials
- Sterile Powder Filled Vials
- Steriles made Simple℠
- cGMP Oligonucleotide Fill
API/Chemistry
- cGMP API Manufacturing
- cGMP Custom Peptide Synthesis
- Custom Small Molecules Synthesis
Health Canada Establishment License
Stegram Pharmaceuticals Business Strategy
Stegram Pharmaceuticals Business Strategy
Since its founding in 1989, Stegram Pharmaceuticals has grown to become a leading pharmaceutical services company, providing discovery, development and manufacturing support to our global customer base The company’s strategy has always been to provide world class scientific services to our customers, with a focus on quality and innovation.
The company began operations in a small lab at Oxford University in 1989, primarily focusing on meeting the chemical needs of local researchers, including hard-to-find or difficult chemical synthesis products. The company became known for its strong chemistry expertise and expanded both its operational lab footprint as well as its customer base. With the provision of larger scale chemical synthesis, Stegram Pharmaceuticals made a strategic decision to add cGMP manufacturing capabilities to support the demand of its customers.
By 2000, Stegram Pharmaceuticals had outgrown its operational space and moved to its current 42,000 square foot (3,900 square meter) facility in Toronto. This additional space allowed Stegram Pharmaceuticals to strategically invest in adding more comprehensive lab services, formulation development services, finished dose manufacturing (including sterile injectables and solid oral capsules) and large scale chemistry and research capabilities.
The objective is to focus on offering pharmaceutical services that meet our customer’s evolving needs and add value by making their supply choices simpler. Today Dalton boasts a fully integrated service offering everything from discovery and research all the way through to small scale cGMP commercial manufacturing. We Discover, Develop, and Manufacture.
Stegram pharmaceutical
72 high Beeches, Banstead, surrey,Sm7 1NW United Kingdom.
reach us at : [email protected]
Phone: +44(0)8712455161
72 high Beeches, Banstead, surrey,Sm7 1NW United Kingdom.
reach us at : [email protected]
Phone: +44(0)8712455161
copyright© 2022 stegrampharma.co.uk